PMID 23319032
GLP-1 drugs may help by: Supporting weight loss Improving blood sugar control Lowering appetite and calorie intake Reducing strain linked with Excess body weight Improving some cardiometabolic markers Possibly affecting inflammation pathways Supporting better long-term risk management However, no patient should see these medicines as a quick fix
Small meals are easier to tolerate when appetite is reduced
Int J Obes 34(11):15591565 Garrido-Snchez L, Garca-Fuentes E, Fernndez-Garca D, Escote X, Alcaide J, Perez-Martinez P, Vendrell J, Tinahones FJ (2012) Zinc-alpha 2-glycoprotein gene expression in adipose tissue is related with insulin resistance and lipolytic genes in morbidly obese patients
While semaglutide has demonstrated remarkable efficacy for appetite control and sustainable weight loss, knowing what to expect regarding potential adverse effects helps you make informed decisions and manage your therapy effectively
The estrogen is there to relieve symptoms